Valuation: Novogenia AG

Market Cap 78M 88.99M 72.1M 66.31M 125M 8.58B 127M 862M 338M 4.2B 334M 327M 14.47B P/E 2025
155x
P/E 2026 * -12.7x
Enterprise Value 21.9M 24.99M 20.24M 18.62M 35.13M 2.41B 35.69M 242M 94.89M 1.18B 93.82M 91.78M 4.06B EV / Sales 2025
0.85x
EV / Sales 2026 * 1.16x
Free-Float
42.5%
Yield 2025 *
6.23%
Yield 2026 * 6.62%
1 day+15.79%
1 week-0.75%
Current month-7.69%
1 month-3.65%
3 months-22.81%
6 months-28.26%
Current year-15.92%
1 week 5.7
Extreme 5.7
6.65
1 month 5.7
Extreme 5.7
7.9
Current year 5.7
Extreme 5.7
12.1
1 year 5.5
Extreme 5.5
12.1
3 years 4.8
Extreme 4.8
12.1
5 years 4.8
Extreme 4.8
12.1
10 years 4.8
Extreme 4.8
12.1
Manager TitleAgeSince
Chief Executive Officer 43 14/03/2021
Director of Finance/CFO - -
Chief Investment Officer - 31/12/2022
Director TitleAgeSince
Director/Board Member - -
Chairman 63 22/06/2021
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+15.79%-0.75% - - 89.26M
-0.49%-3.58%-0.84%+2.13% 49.18B
-3.10%-0.13%+378.16%+584.97% 39.58B
-0.46%+2.77%+7.01%+61.95% 34.69B
-1.14%-0.97%+29.30%-9.20% 34.42B
-1.82%-1.48%+0.52%+32.02% 27.11B
-3.54%-4.12% - - 16.21B
-1.82%+0.74%+72.92%+116.33% 15.36B
+1.17%+3.10%+15.87%+16.79% 14.05B
-2.25%+0.28%+19.29%-32.68% 13.02B
Average +0.83%-0.31%+65.28%+96.54% 27.07B
Weighted average by Cap. -0.74%-0.56%+78.21%+121.16%

Financials

2025 2026 *
Net sales 56M 63.9M 51.77M 47.61M 89.83M 6.16B 91.28M 619M 243M 3.01B 240M 235M 10.39B 57.25M 65.32M 52.92M 48.67M 91.83M 6.3B 93.3M 633M 248M 3.08B 245M 240M 10.62B
Net income 3.3M 3.76M 3.05M 2.81M 5.29M 363M 5.38M 36.47M 14.3M 178M 14.14M 13.83M 612M -6.1M -6.96M -5.64M -5.19M -9.78M -671M -9.94M -67.42M -26.43M -328M -26.13M -25.56M -1.13B
Net Debt -56.1M -64M -51.86M -47.69M -89.99M -6.17B -91.43M -620M -243M -3.02B -240M -235M -10.4B -11.6M -13.23M -10.72M -9.86M -18.61M -1.28B -18.91M -128M -50.26M -624M -49.7M -48.61M -2.15B
Logo Novogenia AG
Novogenia AG, formerly Darwin AG, is a Germany-based company, which operates as a biotechnology company. The Company is engaged in production and distribution of personalized dietary supplements and cosmetics. It offers Deoxyribonucleic Acid (DNA), genetic and blood analyses in the lifestyle segment. In addition, test results are primarily used to produce dietary supplements and cosmetics. The Company is active in Pharmaceutical and medical device trading segment as well. It uses artificial intelligence (AI) to create personalized solutions from scientific laboratory analysis data (personalized infusion therapies and In Vitro Fertilization (IVF)/reproductive genetics).
Employees
204
Date Price Change Volume
20/07/26 6.600 +15.79% 100
17/07/26 €5.700 -9.52% 0
16/07/26 €6.300 -3.08% 50
15/07/26 €6.500 -1.52% 0
14/07/26 €6.600 0.00% 0
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.500EUR
Average target price
19.38EUR
Spread / Average Target
+198.08%

Annual profits - Rate of surprise